InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Rothwell, Alexander John. Director active across 1 company, notably Eupraxia Pharmaceuticals Inc.. Cumulatively, 5 filings have been logged. History available since 15 December 2025. The latest transaction was filed on 15 June 2026 (50 - Grant of options). Regulator: SEDI. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Alexander John Rothwell is a declarant linked to Eupraxia Pharmaceuticals Inc. on XTSE. The 5 filings in the sampled recent filings cover the period from 2025-12-19 to 2026-06-18, and the most common transaction nature is 56 - Grant of rights.